Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Overall survival analyses for CN-AML patients

From: MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia

Variables Univariate analysis Multivariate analysis
P value HR (95%) P value HR (95%)
miR-362-5p 0.028 1.615 (1.048, 2.488) 0.045 1.599 (1.011, 2.528)
WBC < 0.001 1.005 (1.003, 1.008) < 0.001 1.006 (1.003, 1.009)
Hemoglobin 0.242 0.995 (0.987, 1.003) 0.297 0.995 (0.987, 1.004)
Age 0.006 1.02 (1.006, 1.035) 0.005 1.022 (1.007, 1.038)
FLT3-ITD 0.654 1.136 (0.65, 1.987) 0.723 1.11 (0.622, 1.982)
CEBPADM& 0.014 0.352 (0.153, 0.809) 0.007 0.312 (0.133, 0.732)
NPM1 0.884 1.038 (0.629, 1.712) 0.039 0.547 (0.309, 0.969)
DNMT3A 0.157 1.58 (0.838, 2.979) 0.356 1.376 (0.699, 2.711)
IDH1 0.043 1.879 (1.019, 3.466) 0.125 1.662 (0.868, 3.183)
IDH2 0.613 0.849 (0.45, 1.601) 0.196 0.644 (0.331, 1.254)
  1. MiR-362-5p: high vs low expression, Age, WBC and hemoglobin are used as continuous variables
  2. DM& double allele mutations